Why the FDA Was Wrong to Delay Authorization of Vaccines for Kids Under 5

Document Type

Article

Publication

Washington Post

Year

2022

Abstract

The Food and Drug Administration made the wrong call when it announced last week that it will delay authorization of the Pfizer-BioNTech vaccine for children under 5.

The move is likely to leave young children without access to the shots for two months or more. The FDA and Centers for Disease Control and Prevention should be removing roadblocks to vaccinating young children, not erecting them.

Share

COinS